Dr. Jared Baeten, MD, PhD, is Senior Vice President and Virology Therapeutic Area Head at Gilead Sciences, leading HIV, viral hepatitis, and pandemic virus programs. With over 20 years of global HIV research experience, he has led landmark breakthroughs, including HIV PrEP and long-acting HIV therapies. Formerly a Professor at the University of Washington, he is committed to equity and ending the HIV epidemic worldwide.